Hematology Today—April 27, 2026
This week’s Hematology update highlights regulatory approvals, extended review…
Cell and Gene Therapy Today—April 23, 2026
This week’s Gene and Cell Therapy update highlights regulatory momentum,…
In Vivo CAR-T: Stress-Testing the Lilly–Kelonia Deal with AI-Powered Wargaming
Why the Lilly–Kelonia Deal Matters for In Vivo CAR-T Download the…
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash…
Hematology Today—April 20, 2026
This week’s Hematology update highlights regulatory progress, early- and…
Hematology Today—April 6, 2026
This week’s Hematology update highlights regulatory momentum, advancing cell…
Cell and Gene Therapy Today—April 2, 2026
This week’s Gene and Cell Therapy update highlights regulatory progress,…
Hematology Today—March 30, 2026
This week’s Hematology update highlights regulatory progress, evolving…
Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel)
Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel) Professional…
Hematology Today—February 9, 2026
This weekly Hematology update covers regulatory actions, clinical trial…
Hematology Today—February 2, 2026
This weekly update in Hematology covers regulatory actions, late-stage clinical…
Hematology Video Recap—January 26, 2026
This biweekly hematology video covers regulatory actions, clinical progress in…



